We actively engage with our clients to provide education on appropriate use, ensure robust PA criteria for new and existing medications, and track outcomes to confirm that our approach delivers positive results
In this article, We explore how GLP-1 weight loss medications may contribute to muscle loss, the risks involved, and how to mitigate these effects
Firstly, ketone bodies act as ligands for several G protein coupled receptors, thus orchestrating cellular responses and acting as signaling molecules in pathways related to lipid metabolism and cellular growth ( Clinical applicability of KDs is also reported for both autosomal dominant polycystic kidney disease (ADPKD) and cancer
The trial met all primary and key secondary endpoints, demonstrating significant improvements in both weight loss and pain reduction at 68 weeks
Improves skin texture, leaving it smoother and more radiant